妥洛特罗透皮贴剂体外一致性评价及质量标准特性对产业化影响

檀华进, 关晶, 何淑旺, 方夏琴, 靳雯臻, 乔培香, 张宇佳,谭晓川, 张建民, 郑稳生

中国药学杂志 ›› 2019, Vol. 54 ›› Issue (21) : 1758-1765.

PDF(2279 KB)
PDF(2279 KB)
中国药学杂志 ›› 2019, Vol. 54 ›› Issue (21) : 1758-1765. DOI: 10.11669/cpj.2019.21.006
药物制剂产业化新技术专栏

妥洛特罗透皮贴剂体外一致性评价及质量标准特性对产业化影响

  • 檀华进1,2, 关晶3, 何淑旺4, 方夏琴1, 靳雯臻1, 乔培香1, 张宇佳1,谭晓川1, 张建民3, 郑稳生1*
作者信息 +

In Vitro Consistency Evaluation of Tulobuterol Patch and The Impact of Quality Standard Characteristics on Industrialization

  • TAN Hua-jin1,2, GUAN Jin3, HE Shu-wang4, FANG Xia-qin1, JIN Wen-zhen1, QIAO Pei-xiang1, ZHANG Yu-jia1, TAN Xiao-chuan1, ZHANG Jian-min3, ZHENG Wen-sheng1*
Author information +
文章历史 +

摘要

目的 制备妥洛特罗透皮贴剂,进行体外一致性评价及探究质量标准特性对产业化的影响。方法 以聚异丁烯B50、聚丁烯、石油树脂为辅料制备妥洛特罗透皮贴剂;采用高效液相色谱法检测样品中药物含量;以显微镜、差热分析仪、傅立叶变换红外光谱仪、持黏力测试仪、溶出试验仪与透皮试验仪等,评价体外一致性;通过考察贴剂溶出情况及其与透皮相关性、贴剂内药物结晶与体外释药机制,探究质量标准特性对产业化的影响。结果 自制贴剂与参比制剂的药物含量、药物结晶、DSC、MATR、耐热耐冷、黏性及赋形型一致性符合要求;在水或pH 7.4、6.8、4.0的磷酸盐缓冲液的溶出介质中,f2分别为72.516、94.840、90.905和81.760;体外透皮平均渗透率之比为1.02,皮肤滞留量之比为0.88;药物溶解度存在pH依懒性,但体外溶出对pH不敏感,且体外透皮与溶出相关性良好;体外释药受辅料组成与药物结晶等影响。结论 自制贴剂与参比制剂体外评价一致性良好;体外溶出试验可有效反映药物体外透皮渗透吸收过程;并引入制剂内药物结晶评价指标,以提高产业化过程质控检测效率与质量保证;可为本品一致性评价研究、产业化及质量标准改进提供研究参考。

Abstract

OBJECTIVE To prepare of a torotrope transdermal patch for in vitro consistency evaluation and explor of the impact of quality standard characteristics on industrialization. METHODS The tulobuterol transdermal patch was prepared with polyisobutylene B50, polybutene and petroleum resin as auxiliary excipients. The drug content in the sample was determined by high-performance liquid chromatography; in vitro consistency was evaluated by microscopy, differential thermal analysis, Fourier transform infrared spectroscopy, viscosity tester, dissolution Tester, and transdermal tester. The dissolution of the patch and its relationship with transdermal permeation, drug crystallization and in vitro release mechanism of the patch were studied in order to explore the influence of quality standard characteristics on industrialization. RESULTS The self-made patch and the reference preparation have conformity in the drug content, drug crystallization, DSC, MATR, heat resistance, cold resistance, viscosity and shape. The dissolution tests were performed in medium of water and phosphate buffer (pH 7.4, 6.8, 4.0), and the corresponding f2 were 72.516, 94.840, 90.905, and 81.760. The average transdermal permeability ratio is 1.02 and the skin retention ratio is 0.88. The drug solubility is pH dependent while the in vitro dissolution is not sensitive to pH. The correlation between transdermal and dissolution in vitro is good. The in vitro release is affected by the composition of the excipients and the crystallization of the drug. CONCLUSION The self-adhesive and the reference preparation have good consistency in vitro evaluation; the in vitro dissolution test can effectively reflect the transdermal permeation and absorption process of the drug in vitro. The drug crystallization evaluation index in the preparation is introduced to improve the quality control detection efficiency and quality assurance in the industrialization process. Research reference is provided for the consistency evaluation research, industrialization and quality standard improvement of this product.

关键词

妥洛特罗 / 透皮贴剂 / 晶体 / 溶出度 / 质量标准

Key words

tulobuterol / transdermal patch / crystal / dissolution / quality standard

引用本文

导出引用
檀华进, 关晶, 何淑旺, 方夏琴, 靳雯臻, 乔培香, 张宇佳,谭晓川, 张建民, 郑稳生. 妥洛特罗透皮贴剂体外一致性评价及质量标准特性对产业化影响[J]. 中国药学杂志, 2019, 54(21): 1758-1765 https://doi.org/10.11669/cpj.2019.21.006
TAN Hua-jin, GUAN Jin, HE Shu-wang, FANG Xia-qin, JIN Wen-zhen, QIAO Pei-xiang, ZHANG Yu-jia, TAN Xiao-chuan, ZHANG Jian-min, ZHENG Wen-sheng. In Vitro Consistency Evaluation of Tulobuterol Patch and The Impact of Quality Standard Characteristics on Industrialization[J]. Chinese Pharmaceutical Journal, 2019, 54(21): 1758-1765 https://doi.org/10.11669/cpj.2019.21.006
中图分类号: R944   

参考文献

[1] KUME H, KONDO M, ITO Y, et al. Effects of sustained-release tulobuterol on asthma control and beta-adrenoceptor function[J]. Clin Exp Physiol, 2002, 29(12):1076-1083.
[2] FU L X, ZHANG Y J, ZHUANG Y Y, et al. Study on the non-specific anti-inflammation effects of tulobuterol in vitro and in vivo[J]. J China Pharm (中国药房), 2016, 27 (13):1763-1766.
[3] TOSHIO K, YUKIHIRO O, TAKAO F, et al. Effects of the tulobuterol patch on the treatment of acute asthma exacerbations in young children[J]. Allergy Asthma Proc, 2012, 33(3):28-34.
[4] TAN H J, WEN J, ZHANG D, et al. Preparation and evaluation in vivo and in vitro of tulobuterol crystal reservoir patch[J]. Chin Pharm J (中国药学杂志), 2018, 53(15):1290-1295.
[5] XU K X, WEI Y F. Study on the preparation technology of huangqin tongjing cataplasma[J]. China Lice Pharm (中国执业药师), 2010, 7(4):36-38.
[6] XIE M F. How to develop and validate the dissolution test on the quality criteria[J]. Chin J Pharm (中国医药工业杂志), 2012, 43(3):23-32.
[7] TOMOAKI S, YASUTO F, YASUNORI T, et al. Non-destructive analysis of tulobuterol crystal reservoir-type transdermal tapes using near infrared spectroscopy and imaging[J]. J Pharm Biomed Anal, 2013, 74: 14-21.
[8] SAKAMOTO T, PORTIERI A,TADAY P F, et al. Detection of tulobuterol crystal in transdermal patches using terahertz pulsed spectroscopy and imaging[J]. Pharmazie, 2009, 64(6):361-365.
[9] SAKAMOTO T, MATSUBARA T, SASAKURA D, et al. Chemical mapping of tulobuterol in transdermal tapes using microscopic laser Raman spectroscopy[J]. Pharmazie, 2009, 64(3):166-171.
[10] XIE M F. Evalution methods of comparability of dissolution curve[J]. Chin J Pharm (中国医药工业杂志), 2009, 40(4):308-311.

基金

国家“重大新药创制”科技重大专项资助(2014ZX09507006-004)
PDF(2279 KB)

Accesses

Citation

Detail

段落导航
相关文章

/